Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature

被引:43
作者
Pihoker, C
Badger, TM
Reynolds, GA
Bowers, CY
机构
[1] UNIV WASHINGTON, DEPT PEDIAT, SEATTLE, WA 98105 USA
[2] UNIV ARKANSAS MED SCI, DEPT PEDIAT, LITTLE ROCK, AR 72202 USA
[3] TULANE UNIV, DEPT MED, NEW ORLEANS, LA 70112 USA
关键词
D O I
10.1677/joe.0.1550079
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Growth hormone-releasing peptide (GHRP)-2 is a synthetic six amino acid peptide that is a potent GH secretagogue. Although it shares no structural homology with GH-releasing hormone, in clinical studies its actions on the pituitary release of GH are similar. It is effective when administered orally and intranasally. For children with GH deficiency, such noninvasive treatments are most desirable and in need of development. Fifteen children with short stature participated in this study. AU of the children had a height <2 S.D. below mean for age, poor height velocity, delayed bone age, and low serum concentrations of IGF-1. These children had been tested with standard GH secretagogues, e.g. arginine, insulin, and L-dopa. Fifty percent of the children were GH deficient, the remainder had idiopathic short stature. The children received testing with GHRH and GHRP-2 as an acute i.v. bolus of 1 mu g/kg; all children in this study demonstrated a GH response >20 mu g/l. Each child in this study also demonstrated a GH response >10 mu g/l in response to intranasal GHRP-2, in the dose range of 5-20 mu g/kg. The children were administered intranasal GHRP-2, 5-15 mu g/kg, twice a day for 3 months, then three times a day. Fifteen children participated in the study for 6 months; six; of the children have participated for 18-24 months. Height velocity, serum IGF-1, IGF-binding protein 3 (IGFBP-3) and GH-binding protein (GHBP) concentrations, and GH responses to GHRP-2 by i.v. bolus and intranasal spray were examined during treatment. Height velocity increased h-om 3.7 +/- 0.2 cm/year to 6.1 +/- 0.3 cm/year at 6 months, 6.0 +/- 0.4 cm/year at 18-24 months. There were no significant changes in IGF-I or IGF-PBS concentrations, or in acute GH responses to i.v. or intranasal GHRP-2. GHBP concentrations rose significantly, from 439 +/- 63 pmol/l to 688 +/- 48 pmol/l. In this study, intranasal GHRP-2 administration was well tolerated, and produced a modest but significant increase in growth velocity.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 44 条
[1]  
BACH MA, 1996, ENDOCRINE SOC PROGRA, P769
[2]   THE EFFECTS OF GROWTH-HORMONE (GH)-RELEASING PEPTIDES ON GH SECRETION IN PERIFUSED PITUITARY-CELLS OF ADULT MALE-RATS [J].
BADGER, TM ;
MILLARD, WJ ;
MCCORMICK, GF ;
BOWERS, CY ;
MARTIN, JB .
ENDOCRINOLOGY, 1984, 115 (04) :1432-1438
[3]   RADIOIMMUNOASSAY OF GROWTH-HORMONE DEPENDENT INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN IN HUMAN-PLASMA [J].
BAXTER, RC ;
MARTIN, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (06) :1504-1512
[4]   ROLE OF SELECTED ENDOGENOUS PEPTIDES IN GROWTH HORMONE-RELEASING HEXAPEPTIDE ACTIVITY - ANALYSIS OF GROWTH HORMONE-RELEASING HORMONE, THYROID HORMONE-RELEASING HORMONE, AND GONADOTROPIN-RELEASING-HORMONE [J].
BERCU, BB ;
YANG, SW ;
MASUDA, R ;
WALKER, RF .
ENDOCRINOLOGY, 1992, 130 (05) :2579-2586
[5]   DESENSITIZATION STUDIES USING PERIFUSED RAT PITUITARY-CELLS SHOW THAT GROWTH HORMONE-RELEASING HORMONE AND HIS-D-TRP-ALA-TRP-D-PHE-LYS-NH2 STIMULATE GROWTH-HORMONE RELEASE THROUGH DISTINCT RECEPTOR-SITES [J].
BLAKE, AD ;
SMITH, RG .
JOURNAL OF ENDOCRINOLOGY, 1991, 129 (01) :11-19
[6]  
BORKENSTEIN M, 1986, ACTA ENDOCR-COP S, V275, P135
[7]   THE GROWTH HORMONE-RELEASING ACTIVITY OF A SYNTHETIC HEXAPEPTIDE IN NORMAL MEN AND SHORT STATURED CHILDREN AFTER ORAL-ADMINISTRATION [J].
BOWERS, CY ;
ALSTER, DK ;
FRENTZ, JM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (02) :292-298
[8]  
BOWERS CY, 1993, J PEDIATR ENDOCRINOL, V6, P21
[9]   ON THE ACTIONS OF THE GROWTH HORMONE-RELEASING HEXAPEPTIDE, GHRP [J].
BOWERS, CY ;
SARTOR, AO ;
REYNOLDS, GA ;
BADGER, TM .
ENDOCRINOLOGY, 1991, 128 (04) :2027-2035
[10]   ON THE INVITRO AND INVIVO ACTIVITY OF A NEW SYNTHETIC HEXAPEPTIDE THAT ACTS ON THE PITUITARY TO SPECIFICALLY RELEASE GROWTH-HORMONE [J].
BOWERS, CY ;
MOMANY, FA ;
REYNOLDS, GA ;
HONG, A .
ENDOCRINOLOGY, 1984, 114 (05) :1537-1545